Public Comment for the 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation

Public Comment Period:
January 8, 2026 – February 9, 2026

We would like to invite you to participate in the review of the draft version of the 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation. This document aims to present updated and new measures to evaluate the care of patients with atrial fibrillation (AF) in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. This document also helps accomplish ACC and AHA's mission of fostering optimal cardiovascular care and disease prevention, and the AHA’s mission of being a relentless force for a world of longer, healthier lives.

We invite your council to participate in this public comment period and appreciate your willingness to provide important feedback on these measures.

Public Comment for the 2026 AHA/ACC Atrial Fibrillation Measures – Fill out form

Start/End Dates: January 8 to February 9, 2026